Cyclopropyl amines as modulators of the histamine H3 receptor

Details for Australian Patent Application No. 2006292598 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Allison, Brett D.; Carruthers, Nicholas I.; Letavic, Michael A.; Grice, Cheryl A.

Agent Shelston IP

Pub. Number AU-B-2006292598

PCT Pub. Number WO2007/035425

Priority 60/717,659 16.09.05 US

Filing date 14 September 2006

Wipo publication date 29 March 2007

Acceptance publication date 21 June 2012

International Classifications

C07D 211/38 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/00 Drugs for disorders of the nervous system

C07D 265/30 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 295/192 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/035425 Priority application(s): WO2007/035425

21 June 2012 Application Accepted

  Published as AU-B-2006292598

18 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006292602-Predictive contract system and method

2006292596